Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 125S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Radiotherapy 97Paclitaxel 97Bevacizumab 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54toripalimab 53Sorafenib 53Folfox protocol 53Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Transanal Endoscopic Surgery × Gastrointestinal × Clear all
NCT03217773 2019-09-17

ESD Versus TAMIS for Early Rectal Neoplasms

Chinese University of Hong Kong

Phase NA Unknown
114 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03431428 2018-02-13

Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Liaoning Cancer Hospital & Institute

Phase 3 Unknown
477 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡